Kirk is a postdoctoral research associate in the Cardio-Respiratory Interface Section of the National Heart and Lung Institute. Kirk completed a BSc in Biological Sciences at the University of Reading and secured MRC funding for his PhD studies at the University of Leicester. Upon completion of his PhD in 2016 he took up a postdoctoral researcher position at Anglia Ruskin University on a British Heart Foundation funded project. Kirk joined Dr Michael Emerson’s Platelet Biology Group in January 2017 and is investigating the impact of antiretroviral therapies on platelet function.
Kirk is actively involved in public engagement initiatives having run three Pint of Science events in 2018 and coordinating the College's 2019 Festival (28 events, 1,500 attendees). He will continue to coordinate Pint of Science for 2020, so get in touch if you want to get involved. Kirk also developed and delivered a public engagement event for the 2019 LGBT STEM day, which showcased LGBT researchers from Universities across London.
et al., 2021, Fibrinogen-mimicking, multi-arm nanovesicles for human thrombus-specific delivery of tissue plasminogen activator and targeted thrombolytic therapy, Science Advances, Vol:7, ISSN:2375-2548
Taylor KA, Little G, Gibbins JM, 2021, Mind the gap: connexins and pannexins in platelet function, Platelets, ISSN:0953-7104
Taylor KA, 2020, EDI(torial): equality, diversity, and inclusion and platelets-2021, Platelets, Vol:32, ISSN:0953-7104, Pages:3-4
et al., 2020, HIV antivirals affect endothelial activation and endothelial-platelet crosstalk., Circulation Research, Vol:127, ISSN:0009-7330, Pages:1365-1380
et al., 2020, Modelling endothelial function in vitro and via blood sampling to assess cardiovascular risk in people living with HIV, JOHN WILEY & SONS LTD, Pages:105-105